- Home
- SHOT vs CVKD Comparison
SHOT vs CVKD Comparison
Compare SHOT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- CVKD
- Stock Information
- Founded
- SHOT 2018
- CVKD 2022
- Country
- SHOT United States
- CVKD United States
- Employees
- SHOT N/A
- CVKD N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- SHOT Health Care
- CVKD Health Care
- Exchange
- SHOT Nasdaq
- CVKD Nasdaq
- Market Cap
- SHOT 30.4M
- CVKD 29.5M
- IPO Year
- SHOT 2020
- CVKD 2023
- Fundamental
- Price
- SHOT $0.46
- CVKD $12.71
- Analyst Decision
- SHOT
- CVKD Strong Buy
- Analyst Count
- SHOT 0
- CVKD 1
- Target Price
- SHOT N/A
- CVKD $32.00
- AVG Volume (30 Days)
- SHOT 6.3M
- CVKD 36.2K
- Earning Date
- SHOT 08-13-2025
- CVKD 08-06-2025
- Dividend Yield
- SHOT N/A
- CVKD N/A
- EPS Growth
- SHOT N/A
- CVKD N/A
- EPS
- SHOT N/A
- CVKD N/A
- Revenue
- SHOT $573,336.00
- CVKD N/A
- Revenue This Year
- SHOT N/A
- CVKD N/A
- Revenue Next Year
- SHOT N/A
- CVKD N/A
- P/E Ratio
- SHOT N/A
- CVKD N/A
- Revenue Growth
- SHOT 69.32
- CVKD N/A
- 52 Week Low
- SHOT $0.23
- CVKD $5.70
- 52 Week High
- SHOT $1.77
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- SHOT 54.76
- CVKD 49.98
- Support Level
- SHOT $0.35
- CVKD $11.00
- Resistance Level
- SHOT $0.48
- CVKD $13.56
- Average True Range (ATR)
- SHOT 0.06
- CVKD 1.15
- MACD
- SHOT 0.01
- CVKD 0.25
- Stochastic Oscillator
- SHOT 46.94
- CVKD 80.97
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.